Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Preferred Stock was decided 1997

Under the RISK FACTORS warning section, the "We may issue Preferred Stock.." was added for the first time ever, and appeared in the year end filing made public in August; 2 months ago.

You were put on specific public notice at that point.

Share
New Message
Please login to post a reply